@farmerman,
A study in Gangelt Germany seems to give us some cause for cautious optimism. The study , based upon 1000 individuals looked at test data from antigen AND antibody results. It appears that the population has "built in" about a 37% populational immunity. This, is only very early data but it means that a 37% immunity is a "BASELINE " number, Immunity could follow the "herd immunity" data from other SARs .(Dr John Campbell was explaining that we need to conduct more testing to flesh this out)>
US is, slowly catching up to China, and other countries (The highest testing rate is in China and Germany at 9% of targeted population)
Whats really important is that, besides the possibility of populational immunity growing and giving us time to develop a vaccine, the Case Fatality Rate (CFR) that was modeled by Johns Hopkins may be too high.
Hopkins calculated a CFR of about 1.98%, while projecting, based on the Gangelt Germany data, that CFR may be lowered to 0.38%
A little bit of hopeful news.Still, I wish wed be doing more testing(antigen and antibody) rather than just arguing about it. Weve still done MORE individual testing than most other countries (except China and S Korea). Were about 6.3% but those last few %points are the tough ones because it accounts for huge numbers based on the size of our population.
The studies are availbale I just didnt transfer it over from John Campbells youtube updates.